98 related articles for article (PubMed ID: 4079598)
1. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J
Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
Sava G; Giraldi T; Lassiani L; Nisi C
Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
Sava G; Giraldi T; Nisi C; Bertoli G
Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
5. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
Sava G; Giraldi T; Zupi G; Sacchi A
Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
[TBL] [Abstract][Full Text] [Related]
6. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
Varnavas A; Nisi C; Lassiani L; Sava G; Perissin L; Boccù E
Arzneimittelforschung; 1991 Nov; 41(11):1168-72. PubMed ID: 1810263
[TBL] [Abstract][Full Text] [Related]
8. Activity of 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt in M 5076/73A ovarian reticular cell sarcoma of the mouse.
Colombo T; Garattini S; Lassiani L; D'Incalci M
Cancer Treat Rep; 1982 Nov; 66(11):1945-8. PubMed ID: 6754075
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM).
Sava G; Giraldi T; Tomasić J; Hrsak I
Cancer Immunol Immunother; 1983; 15(2):84-6. PubMed ID: 6553516
[TBL] [Abstract][Full Text] [Related]
10. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG
Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005
[TBL] [Abstract][Full Text] [Related]
11. Effects of dimethyltriazenes combined with surgery and non-specific immunotherapy in mice bearing Lewis lung carcinoma lines.
Sava G; Perissin L; Zorzet S; Tomasić J
Anticancer Res; 1985; 5(3):301-5. PubMed ID: 4015044
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma.
Sava G; Tomasic J; Hrsak I
Cancer Immunol Immunother; 1984; 18(1):49-53. PubMed ID: 6567478
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines.
Sava G; Zorzet S; Perissin L
Anticancer Res; 1985; 5(5):511-5. PubMed ID: 4062252
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.
Mrakovcić-Sutić I; Radosević-Stasić B; Simin M; Muhvić D; Rukavina D
Mediators Inflamm; 2002 Apr; 11(2):129-35. PubMed ID: 12061425
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan.
Rose WC; Reed FC; Siminoff P; Bradner WT
Cancer Res; 1984 Apr; 44(4):1368-73. PubMed ID: 6704958
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
[TBL] [Abstract][Full Text] [Related]
17. The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers.
Muhvić D; El-Samalouti V; Flad HD; Radosević-Stasić B; Rukavina D
Mediators Inflamm; 2001 Jun; 10(3):155-62. PubMed ID: 11545252
[TBL] [Abstract][Full Text] [Related]
18. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
Giraldi T; Houghton PJ; Taylor DM; Nisi C
Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
Colombo T; D'Incalci M
Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of B-16 melanoma with peptidoglycan monomer.
Hrsak I; Tomasić J; Osmak M
Eur J Cancer Clin Oncol; 1983 May; 19(5):681-6. PubMed ID: 6683639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
